期刊
EUROPEAN JOURNAL OF IMMUNOLOGY
卷 38, 期 9, 页码 2534-2547出版社
WILEY
DOI: 10.1002/eji.200737867
关键词
kinases; klf2; MAPK; signal transduction; T cells
类别
资金
- UK Medical Research Council (SA)
- Royal Society (CM)
- Astra-Zeneca
- Boehringer-Ingelheim
- GlaxoSmithKline
- Merk and Co
- Merk KGaA and Pfizer
- MRC [MC_U127081014] Funding Source: UKRI
- Medical Research Council [MC_U127081014] Funding Source: researchfish
ERK5 has been implicated in regulating the MEF2-dependent genes Klf2 and nur77 downstream of the TCR and the maintenance of expression of CD62L on peripheral T cells. Based on this data, knockout of ERK5 would be predicted to compromise T-cell development and the maintenance of T cells in the periphery. Using an ERK5 conditional knockout, driven by CD4-CRE or Vav-CRE transgenes resulting in the loss of ERK5 in T cells, we have found that ERK5 is not required for T-cell development. In addition, normal numbers of T cells were found in the spleens and lymph nodes of these mice. We also find that TCR stimulation is not a strong signal for ERK5 activation in primary murine T cells. ERK5 was found to contribute to the induction of Klf2 but not nur77 mRNA following TCR activation. Despite the reduction in Klf2 mRNA, no effect was seen in ERK5 knockouts on either the mRNA levels for the Klf2 target genes CD62L, CCR7 and S1P, or the cell surface expression of CD62L. These results suggest that while ERK5 does contribute to Klf2 regulation in T cells, it is not essential for the expression of CD62L or T-cell survival.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据